Candesartan cilexetil – a review of effects on cardiovascular complications in hypertension and chronic heart failure

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.7, 2007-07, pp. : 1693-1705

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hemodynamic and Hormonal Effects of the Angiotensin II Antagonist, Candesartan Cilexetil, in Patients with Congestive Heart Failure

Cardiology, Vol. 93, Iss. 3, 2000-08 ,pp. : 175-182

Karger

Access to resources Recommend Favorite

Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 82, Iss. 4, 2016-10 ,pp. : 974-982

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension

By Bönner Gerd Fuchs Winfried

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 935-940

Informa Healthcare

Access to resources Recommend Favorite

Thirst in chronic heart failure: a review

JOURNAL OF CLINICAL NURSING, Vol. 24, Iss. 7-8, 2015-04 ,pp. : 916-926

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin II antagonists – therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy

By Ribeiro Artur Beltrame

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 1-16

Informa Healthcare

Access to resources Recommend Favorite